Literature DB >> 10608761

Reduced mobilization of CD34+ stem cells in advanced human immunodeficiency virus type 1 disease.

R T Schooley1, J Mladenovic, A Sevin, S Chiu, S A Miles, R J Pomerantz, T B Campbell, D Bell, D Ambruso, R Wong, A Landay, R W Coombs, L Fox, M Kamoun, J Jacovini.   

Abstract

Granulocyte colony-stimulating factor (r-met Hu G-CSF; filgrastim; 10 microgram/kg/day for 7 days) was used to mobilize CD34+stem cells into the peripheral blood of human immunodeficiency virus type 1 (HIV-1)-infected individuals and a group of HIV-1-uninfected donors as a measure of immunologic reserve in HIV-1-infected people. G-CSF mobilized CD34+ cells of HIV-1-infected individuals with cell counts >500 CD4+ cells/mm3, as well as in HIV-1-uninfected donors. In contrast, CD34 cell mobilization was significantly blunted in HIV-1-infected individuals with cell counts <500 CD4+ cells/mm3 (<200 cell days vs. >650 cell days, P<.0005, compared with the >500 CD4+ cell cohort). At least 1.75x10(7) CD34 cells were harvested by leukapheresis from patients in each study cohort. CD34+ cell viability and the ability to differentiate precursor cells into myeloid and erythroid progenitor cells were not affected by HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10608761     DOI: 10.1086/315168

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  8 in total

Review 1.  Hematopoietic stem cell transplantation in patients infected with HIV.

Authors:  David Serrano; Pilar Miralles; Pascual Balsalobre; José Luis Díez-Martin; Juan Berenguer
Journal:  Curr HIV/AIDS Rep       Date:  2010-08       Impact factor: 5.071

Review 2.  Neutropenia during HIV infection: adverse consequences and remedies.

Authors:  Xin Shi; Matthew D Sims; Michel M Hanna; Ming Xie; Peter G Gulick; Yong-Hui Zheng; Marc D Basson; Ping Zhang
Journal:  Int Rev Immunol       Date:  2014-03-21       Impact factor: 5.311

Review 3.  Stem cell transplantation in HIV-infected patients.

Authors:  Amrita Krishnan
Journal:  Curr Opin HIV AIDS       Date:  2009-01       Impact factor: 4.283

4.  Stem cell mobilization in HIV seropositive patients with lymphoma.

Authors:  Alessandro Re; Chiara Cattaneo; Cristina Skert; Pascual Balsalobre; Mariagrazia Michieli; Mark Bower; Andrés J M Ferreri; Marcus Hentrich; José M Ribera; Bernardino Allione; Philipp Schommers; Silvia Montoto; Camillo Almici; Pierino Ferremi; Mario Mazzucato; Salvatore Gattillo; Salvatore Casari; Michele Spina; José L Diez-Martin; Umberto Tirelli; Giuseppe Rossi
Journal:  Haematologica       Date:  2013-08-23       Impact factor: 9.941

Review 5.  Gene Therapy Approaches to Functional Cure and Protection of Hematopoietic Potential in HIV Infection.

Authors:  Tetsuo Tsukamoto
Journal:  Pharmaceutics       Date:  2019-03-11       Impact factor: 6.321

Review 6.  Granulocyte macrophage colony-stimulating factor has come of age: From a vaccine adjuvant to antiviral immunotherapy.

Authors:  Maria Petrina; Jacqueline Martin; Sameh Basta
Journal:  Cytokine Growth Factor Rev       Date:  2021-01-09       Impact factor: 7.638

7.  Development of hematopoietic stem cell based gene therapy for HIV-1 infection: considerations for proof of concept studies and translation to standard medical practice.

Authors:  David L DiGiusto; Rodica Stan; Amrita Krishnan; Haitang Li; John J Rossi; John A Zaia
Journal:  Viruses       Date:  2013-11-22       Impact factor: 5.048

Review 8.  Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing.

Authors:  P Alvarez; E Carrillo; C Vélez; F Hita-Contreras; A Martínez-Amat; F Rodríguez-Serrano; H Boulaiz; R Ortiz; C Melguizo; J Prados; A Aránega
Journal:  Biomed Res Int       Date:  2013-06-17       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.